These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15937602)

  • 1. HRT use among women tested for BRCA1/2 mutations following publication of the women's health initiative study results.
    Vallée MH; Rouleau I; Chiquette J; Plante M; Simard J; Dorval M
    J Obstet Gynaecol Can; 2005 Apr; 27(4):321; author reply 322. PubMed ID: 15937602
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of hormone replacement therapy by postmenopausal women after publication of the Women's Health Initiative Trial.
    Ness J; Aronow WS; Newkirk E; McDanel D
    J Gerontol A Biol Sci Med Sci; 2005 Apr; 60(4):460-2. PubMed ID: 15933383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women's Health Issues for BRCA Mutation Carriers.
    Sabatini ME; Ellisen LW
    Am Soc Clin Oncol Educ Book; 2016; 35():14-7. PubMed ID: 27249681
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical update on hormone replacement therapy.
    Holloway D
    Br J Nurs; 2010 Apr 22-May 13; 19(8):496, 498-504. PubMed ID: 20505615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the Women's Health Initiative study publication on hormone replacement therapy use among women who have undergone BRCA1/2 testing.
    Dorval M; Vallée MH; Plante M; Chiquette J; Gaudet M; Simard J
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):157-60. PubMed ID: 17220345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy.
    Haskell SG
    J Womens Health (Larchmt); 2004 May; 13(4):438-42. PubMed ID: 15186661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
    Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
    J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health beliefs and women's use of hormone replacement therapy.
    McGinley AM
    Holist Nurs Pract; 2004; 18(1):18-25. PubMed ID: 14765688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of women on long-term hormone replacement therapy and their attitude to suggested cessation.
    Horner E; Fleming J; Studd J
    Climacteric; 2006 Dec; 9(6):459-63. PubMed ID: 17085379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk of BRCA1/2 mutation carriers: A review.
    van Westerop LL; Arts-de Jong M; Hoogerbrugge N; de Hullu JA; Maas AH
    Maturitas; 2016 Sep; 91():135-9. PubMed ID: 27451331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on the Women's Health Initiative trial of hormone replacement therapy.
    Grimes DA; Lobo RA
    Obstet Gynecol; 2002 Dec; 100(6):1344-53. PubMed ID: 12468183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decisions on women's health: menopause and hormone replacement therapy.
    Visser A
    Patient Educ Couns; 2004 May; 53(2):119. PubMed ID: 15140449
    [No Abstract]   [Full Text] [Related]  

  • 13. Women's awareness and knowledge of hormone therapy post-Women's Health Initiative.
    Rigby AJ; Ma J; Stafford RS
    Menopause; 2007; 14(5):853-8. PubMed ID: 17429334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in practice since the publication in 2007 of further results from the Women's Health Initiative and the Million Women Study.
    Cust MP
    Menopause Int; 2007 Dec; 13(4):141-3. PubMed ID: 18088523
    [No Abstract]   [Full Text] [Related]  

  • 15. Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.
    Bluman LG; Rimer BK; Regan Sterba K; Lancaster J; Clark S; Borstelmann N; Iglehart JD; Winer EP
    Psychooncology; 2003; 12(5):410-27. PubMed ID: 12833555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
    Lemay A
    J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
    Barber CA; Margolis K; Luepker RV; Arnett DK
    J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observations and advertising: controversies in the prescribing of hormone replacement therapy.
    Katz A
    Health Care Women Int; 2003 Dec; 24(10):927-39. PubMed ID: 14742130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.
    Bakos AD; Hutson SP; Loud JT; Peters JA; Giusti RM; Greene MH
    Health Expect; 2008 Sep; 11(3):220-31. PubMed ID: 18816319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women's health. Making choices.
    Button F
    Nurs Manag (Harrow); 1999 Mar; 5(10):23-7. PubMed ID: 10222982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.